Bio-Rad Laboratories Company Profile.
Bio-Rad Laboratories, Inc. was founded in 1952 in Berkeley, California. The company was initially engaged in the development and production of specialty chemicals used in biochemical, pharmaceutical, and other life science research applications. Today, Bio-Rad manufactures and supplies life science research, healthcare, analytical chemistry, and other markets with products and systems used to separate complex chemical and biological materials and to identify, analyze, and purify their components.
Bio-Rad operates in six industry segments: Life Science Research, Clinical Diagnostics, Process Separations, Food Science, Spectroscopy, and Life Science Education. All segments operate worldwide. Bio-Rad's customers include hospitals, major research institutions, biotechnology and pharmaceutical companies, and secondary and tertiary academic institutions. Bio-Rad's headquarters are in Hercules, California. The company has offices and facilities worldwide and more than 7,000 employees. Bio-Rad had revenues of more than two billion dollars in 2011. The company has been listed on the New York Stock Exchange since October 24, 2008. Before that, Bio-Rad was listed on the American Stock Exchange.
Novartis Vaccines and Diagnostics Company Profile.
Building on more than a decade of dedication to blood safety, Novartis Diagnostics is developing a future of innovative solutions for preventive screening and the prediction of health outcomes.
Novartis Diagnostics products are used to test millions of blood donations around the world each year for pathogens such as HIV (the AIDS virus,) hepatitis B and hepatitis C, and West Nile Virus.
More than 80 percent of the U.S. blood supply is tested on Novartis Diagnostics systems to make sure they are safe for transfusion or use in other blood products.